Skip to content Skip to navigation

Siemens: Ready for Takeoff

May 29, 2009
by David Raths
| Reprints
Siemens believes the transition from Invision to Soarian has it positioned for the brave new healthcare world to come

Sam brandt, m.d.

Sam Brandt, M.D.

Looking out over the sprawling Siemens Healthcare campus in a suburban office park outside Philadelphia, Janet Dillione admits that the acquisitions, integration and product development of the last several years have not gone as smoothly or as quickly as anyone at Siemens would have liked.

But without pausing, the CEO of the Health Services business unit adds that she wouldn't trade places with any of her competitors.

“The very good news is that we've already made the technology transition that many others are now going to have to make,” she says. “That's a good feeling for us to have - that while we're challenged to adapt to a lot of other things, we've gotten over that technology hump.”

That hump, as she sees it, was the development of Soarian, a native Web IT platform - both clinical and financial - driven by embedded workflow technology. Now perhaps the bigger challenge is converting the large customer base still on Siemens' earlier product line, Invision, to Soarian.

Besides rolling out the Soarian platform, Siemens also has made several recent acquisitions in the diagnostics field, including Dade Behring, Diagnostic Products Corp., and Bayer Diagnostics. Overall, Siemens Healthcare now has 13 product lines in 30 countries. Dillione runs Health Services, the health IT arm based in Malvern, Pa.

The Germany-based parent company's executives believe their long-term vision of integrating imaging and diagnostics with a strong health IT platform will pay dividends in an era when people may soon be able to have their entire genetic sequence mapped for $100. “How all that patient genetic information interfaces with the healthcare system has huge implications,” says Sam Brandt, M.D., a Siemens vice president and chief medical informatics officer. “That's a game changer.”

Dillione sees herself as having two missions: “One is to compete against my standard competitors - pure HIS players such as McKesson, Cerner, and Epic. The other is to be cognizant of the fact that we're actually building a larger IT platform so that we'll be able to play in that future world of personalized medicine.”

The fact that Siemens can offer the soup-to-nuts approach with imaging and diagnostics such as in-vitro tests and blood gas analyzers - in addition to core clinical software - is no doubt a benefit, and the new Soarian technology gets good reviews from its early users. But did the drawn-out product development process raise concerns among potential customers?

Kent gale

Kent Gale

After Siemens bought Shared Medical Systems (SMS) for about $2.1 billion in 2000, many people in the industry believed it would provide the discipline to help SMS deliver projects on time and budget, a perception that company had struggled with, notes Kent Gale, founder and chairman of research firm KLAS (Orem, Utah). “Well, here we are in 2009 and we are just seeing the fruits of that,” he says. The hospitals using Soarian Financials love it, Gale notes, and the customers using Soarian Clinicals like its capabilities. For those customers, it validates the wait, and they believe the company has come through this transition with a strong product line, he adds. Siemens says Soarian Clinicals has 95 U.S. customers, representing 166 facilities, and Soarian Financials has 27 U.S. customers.

If adoption of Soarian has been slow, Siemens has nevertheless been very effective at halting the exodus of its customer base to competitors.

“Pre-Soarian, I was getting calls every other week from Invision customers who were dissatisfied and looking at other vendors,” says Thomas Handler, M.D., research director of Gartner's healthcare provider services. “Once Soarian was announced, those calls stopped, and the customers decided to wait and see. But that was five years ago,” he adds. “Now they call and ask, ‘When is this going to be real?’ But they still aren't talking about leaving for other vendors.”

Several developments have both strong positives and some negatives for Siemens customers to weigh, Gale maintains.

John glaser, ph.d.

John Glaser, Ph.D.

The company's longevity and long-term focus is a huge positive, he says. In addition, many early users have reported being surprised at how good Soarian Financials actually is. However, Gale claims Siemens has yet to prove Soarian Clinicals' CPOE module works well, which could be a stumbling block. Likewise, many organizations are excited about Soarian's workflow capabilities. Yet Gale says customers want those capabilities to extend to the ambulatory setting, and he notes that Siemens has postponed work on the ambulatory side of Soarian.

Welcome to Malvernia

Arriving at the Siemens headquarters, which Dillione jokingly refers to as “Malvernia,” visitors might momentarily mistake it for engineering department buildings on a university campus. Young people arrive in twos and threes, many in jeans and golf shirts. They walk across manicured green expanses from vast parking lots. But inside, the offices offer a sleeker and more futuristic feel, with security badges required to open every door. The walls are adorned with flat-panel TVs displaying corporate information.